Related Articles
Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project
Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer
Cost-effectiveness and safety of the molecular targeted drugs afatinib, gefitinib and erlotinib as first-line treatments for patients with advanced EGFR mutation-positive non-small-cell lung cancer
Comparison of cost-effectiveness of regorafenib and trifluridine/tipiracil combination tablet for treating advanced and recurrent colorectal cancer
Co-treatment with gemcitabine and nab-paclitaxel exerts additive effects on pancreatic cancer cell death